Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medizinska AkadfiledCriticalMedizinska Akad
Priority to BG9390291ApriorityCriticalpatent/BG51099A1/en
Publication of BG51099A1publicationCriticalpatent/BG51099A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The compounds are applicable in medicine, e.g. for radiotherapy in cancer treatment. They are less toxic and have an optimised sensibilising effect and have the following formula:<IMAGE>where q is 0 or 2. When q is 0, R is OAg and X is 1. When q is 2, R is oxygen and X is 2, n is 1 or 2. According to this method, the respective silver salt of the adenosinemono- or adenosinetriphosphate reacts with 2-deoxycytidine hydrochloride at a 1/1 to 1/3 ratio within a water medium.
BG9390291A1991-02-221991-02-22Adenosinephosphorus derivatives of 2'-deoxycytidine, method for their preparation and application
BG51099A1
(en)